Last updated on December 2016

Nasal Carbon Dioxide for the Symptomatic Treatment of Classical Trigeminal Neuralgia


Brief description of study

A placebo-controlled, single-blind study to evaluate the safety and preliminary efficacy of nasal carbon dioxide for the symptomatic treatment of classical trigeminal neuralgia.

Clinical Study Identifier: NCT02473016

Contact Investigators or Research Sites near you

Start Over

Cynthia Huffman, MD

Meridien Research
Tampa, FL United States
1.75miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.